Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bharat_iyengar
    Member
    • Dec 2012
    • 20

    #1

    Cufflinks statistical model

    I needed a little help in understanding the abundance estimation by
    Cufflinks.
    Please refer to cufflinks supplementary methods.

    Let me reiterate some of the key points/definitions; for the sake of
    convenience of explanation.

    ρ(t) = abundance of transcript t
    α(t) = probability of choosing a transcript t
    [identified by abundance and length]
    β(g) = sum(α(t)) (t belongs to g) = probability of choosing a transcript from
    a locus g
    γ(t) = probability that chosen transcript has given abundance and length

    Question 1: Does that mean that a transcript is fully identified by its
    length and abundance ?

    Question 2: In the parameter estimation section, I didnt quite understand
    how MLE of β becomes X(g)/M.
    Shouldnt it be the solution of ∑ ∂(X(g).log(β(g)))/∂β(g) = 0 ?

    Question 3: I dont understand importance sampling method much, but is
    there an intuitive way of understanding how is γ estimated from input
    variable i.e. reads ?

    FPKM calculation has l(t) in denominator. Cufflinks should accept any
    SAM/BAM file regardless of whether its passed through Tophat. If I pass to
    cufflinks, the reads aligned to transcriptome (refseq), and I dont provide
    any annotations, then:

    Question 4: How is a locus designated ?
    Question 5: How is l(t) estimated for FPKM calculation; length of a
    transcript should be smaller than a locus?


    Finally, how can I use cufflinks without involving genome alignments !?

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...